Insights from leading experts on real-world clinical adoption of Virtual Humans and strategic leadership

How can Virtual Humans be integrated into clinical workflows to deliver real value for the healthcare industry?


In this interview, Christopher Morton, CEO of ELEM Biotech, reflects on the outcomes of the Virtual Human Global Summit II and shares his vision for scaling Virtual Human and biomedical simulation technologies. He discusses the growing alignment between industry, research, and regulators, and the strategic role that ELEM plays in advancing computational medicine globally.


Antoni Gilabert, Director at Hospital del Mar, shares insights on how virtual human technologies can integrate into hospital workflows and support clinical decision-making. He discusses the importance of multidisciplinary collaboration and Barcelona’s key role as a hub for digital health innovation showcased during VHGS II.

You have any question related to Virtual Humans?